Literature DB >> 620210

Normotensive familial phaeochromocytoma with predominant noradrenaline secretion.

A D Ho, G Feurle, K H Gless, W E Brandeis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620210      PMCID: PMC1602613          DOI: 10.1136/bmj.1.6105.81-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  TURNOVER AND METABOLISM OF CATECHOLAMINES IN PATIENTS WITH PHEOCHROMOCYTOMA.

Authors:  J R CROUT; A SJOERDSMA
Journal:  J Clin Invest       Date:  1964-01       Impact factor: 14.808

2.  Pheochromocytoma with predominant epinephrine secretion.

Authors:  L B Page; J W Raker; F R Berberich
Journal:  Am J Med       Date:  1969-10       Impact factor: 4.965

3.  An asymptomatic catecholamine-secreting pheochromocytoma.

Authors:  I Taubman; O H Pearson; A H Anton
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

4.  Chemistry and pharmacology of catecholamine-secreting tumors.

Authors:  W von Studnitz
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

  4 in total
  5 in total

1.  Emergency operation in a patient with asymptomatic pheochromocytoma.

Authors:  A Nonaka; S Kashimoto; K Okuyama; M Kume; T Funayama; T Kumazawa
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

2.  Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations.

Authors:  B D Kirby; J Ham; H B Fairley; N Benowitz; M Schambelan
Journal:  West J Med       Date:  1983-08

Review 3.  [Preoperative α-adrenoceptor block in asymptomatic pheochromocytoma? Pro].

Authors:  L Bracker; S Rath; H Dralle; M Bucher
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

Review 4.  Catecholamines: role in health and disease.

Authors:  R Laverty
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

5.  A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case.

Authors:  M Mannelli; C Pupilli; R Lanzillotti; L Ianni; A Amorosi; G Credi; C Pratesi
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.